USMJ and PURA Signal Full Steam Ahead in Canada and California Recreational Marijuana Markets
March 15 2018 - 9:20AM
InvestorsHub NewsWire
Dallas,
TX -- March 15, 2018 -- InvestorsHub NewsWire
-- North American Cannabis Holdings, Inc. (USOTC:
USMJ) and Puration, Inc. (USOTC: PURA) are continuing to forge
ahead with establishing operations in Canada and California to
position both companies to benefit from the respective legalization
of recreational marijuana. USMJ recently announced a letter
of intent to acquire a company in California that would advance
USMJ’s strategy to enter the recreational marijuana grow and
dispensary markets in California. PURA has recently announced
developments in California to establish an extraction operation and
produce cannabis extract infused beverages for the legal California
recreational marijuana market. Together, USMJ and PURA have
been developing an opportunity to acquire a grow operation in
Canada in advance of the pending nationwide legalization of
recreational marijuana expected this coming July. Management
indicates a letter of intent agreement in Canada that would lead to
USMJ acquiring a grow operation and PURA establishing an extract
facility, is imminent. USMJ recently reported 28% organic
revenue growth with over $400,000 in sales for the first six months
of the fiscal year for 2018. PURA’s sales of EVERx are
increasing rapidly with multiple retail outlets and a new
distribution partner. With solid historical momentum and the
developing expansion opportunities in Canada and California, the
combined management of USMJ and PURA indicate operations are
full-steam-ahead, and that a strategic acquisition is anticipated
to close within the first week of April.
For more information on North American Cannabis Holdings and
Puration visit www.aciconglomerated.com.
Disclaimer/Safe Harbor:
This news release
contains forward-looking statements within the meaning of the
Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur. These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose,
treat, cure, or prevent any disease.
For More Information Contact:
Steven Rash
info@aciconglomerated.com
1-800-861-1350
North American Cannabis (CE) (USOTC:USMJ)
Historical Stock Chart
From Aug 2024 to Sep 2024
North American Cannabis (CE) (USOTC:USMJ)
Historical Stock Chart
From Sep 2023 to Sep 2024